Skip to main content
SpringerLink
Log in

Quetiapine offers promise for difficult-to-treat psychosis complicating Parkinson’ disease

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Juncos JL. Management of psychotic aspects of Parkinson’ disease. J Clin Psychiatry 1999; 60 Suppl. 8: 42–53

    PubMed  Google Scholar 

  2. Young K, Camicioli R, Ganzini L. Neuropsychiatric adverse effects of antiparkinsonian drugs: characteristics, evaluation and treatment. Drugs Aging 1997; 10(5): 367–83

    Article  PubMed  CAS  Google Scholar 

  3. Matheson AJ, Lamb HM. Quetiapine: a review of its clinical potential in the management of psychotic symptoms in Parkinson’ disease. CNS Drugs 2000 Aug: 14(2); 157–72

    Article  CAS  Google Scholar 

  4. Goldstein JM, Litwin LC, Sutton EB, et al. Seroquel: electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 1993 Sep; 112: 293–8

    Article  PubMed  CAS  Google Scholar 

  5. Tandon R, Milner K, Jibson MD. Antipsychotics from theory to practice: integrating clinical and basic data. J Clin Psychiatry 1999; 60 Suppl. 8: 21–8

    PubMed  Google Scholar 

  6. Friedman J, Fernandez H, Jacques C. Quetiapine for the treatment of dopamimetic psychosis in Parkinson’ Disease [poster no. NR699]. Poster presentation. Annual Meeting of the American Psychiatric Association; 1999, May 15–20; Washington, DC.

    Google Scholar 

  7. Targum SD, Abbott BA. Efficacy of quetiapine in Parkinson’ patients with psychosis. J Clin Psychopharmacol 2000; 20(1): 54–60

    Article  PubMed  CAS  Google Scholar 

  8. Fernandez HH, Lannon MC, Friedman JH, et al. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson’ disease. Mov Disord 2000; 15(3): 579–81

    Article  PubMed  CAS  Google Scholar 

  9. Evatt ML, Jewart D, Juncos JL. ‘seroquel’ (ICI 204,636) treatment of psychosis in parkinsonism [abstract]. Mov Disord 1996 Sept; 11: 595

    Google Scholar 

  10. Juncos JL, Evatt ML, Jewart D. Long-term effects of quetiapine fumarate in parkinsonism complicated by psychosis [abstract]. Neurology 1998 Apr; 50 Suppl. 4: A70–1

    Google Scholar 

  11. Juncos J, Yeung P, Sweitzer D, et al. Seroquel (quetiapine) improves psychotic symptoms associated with Parkinson’s Disease [poster no. NR656]. Poster presentation, Annual Meeting of the American Psychiatric Association; 1999 May 15–20; Washington, DC

    Google Scholar 

  12. Juncos JL, Evatt ML, Jewart RD, et al. Long-term Quetiapine treatment for psychosis in patients with Parkinson’s Disease who failed treatment with other atypical antipsychotics. Poster presentation, Presented at the Annual General Meeting of the American College of Neuropsychopharmacology; 1999 Dec 12–16; Acapulco, Mexico

    Google Scholar 

  13. Parsa MA, Greenaway HE, Bastani B. Quetiapine for the treatment of psychosis in Lewy body disease [abstract no. 535]. Biol Psychiatry 2000; 47: 163S

    Article  Google Scholar 

  14. Roberts VJ, Juncos JL, Jewart RD, et al. Cognitive improvement in patients with Parkinson’ disease treated with quetiapine for psychotic symptoms [abstract no. 619]. 6th International Congress of Parkinson’ Disease and Movement Disorders; 2000 Jun 11–15, Barcelona

    Google Scholar 

  15. Kasper S, Muller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Expert Opinion Pharmacotherapy 2000; 1(4): 783–801

    Article  CAS  Google Scholar 

  16. Madhusoodanan S, Brenner R, Cohen CI. Role of atypical antipsychotics in the treatment of psychosis and agitation associated with dementia. CNS Drugs 1999; 12(2): 135–50

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quetiapine offers promise for difficult-to-treat psychosis complicating Parkinson’ disease. Drugs Ther. Perspect 17, 1–5 (2001). https://doi.org/10.2165/00042310-200117180-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117180-00001

Keywords

Search

Navigation